Načítá se...
TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
BACKGROUND: Low frequency coding variants in TREM2 are associated with Alzheimer disease (AD) risk and cerebrospinal fluid (CSF) TREM2 protein levels are different between AD cases and controls. Similarly, TREM2 risk variant carriers also exhibit differential CSF TREM2 levels. TREM2 has three differ...
Uloženo v:
| Vydáno v: | Mol Neurodegener |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6505298/ https://ncbi.nlm.nih.gov/pubmed/31068200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-019-0319-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|